{"public_id":"co_f5a8800566d649ba7ef6b578ad92efce","status":"active","merged_into_public_id":null,"resolved_public_id":"co_f5a8800566d649ba7ef6b578ad92efce","name":"constitutive hCTR2 activity","description":"Basal signaling from the human calcitonin receptor type 2 in the melanophore system.","aliases":[],"types":["phenomenon"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":17639003,"title":"Use of constitutive G protein-coupled receptor activity for drug discovery.","citation_count":103,"url":"https://sah.borca.ai/papers/17639003"}],"claims":[{"public_id":"cl_d457ee8a692f657ab32a4a46a740519d","text":"The constitutive hCTR2 system discriminated positive and negative ligand efficacy, because different hCTR2 ligands either increased or decreased basal activity.","corpus_id":17639003,"url":"https://sah.borca.ai/claims/cl_d457ee8a692f657ab32a4a46a740519d"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_f5a8800566d649ba7ef6b578ad92efce","url":"https://sah.borca.ai/concepts/co_f5a8800566d649ba7ef6b578ad92efce"}